
Denmark’s third-biggest pharmaceutical company is now going in new directions with a bonus program, which all of the company’s employees have the option to participate in.
The change comes in a period of great transformations for Leo Pharma, including the closing of 1,000 positions over the next two years, as the company edges closer to its expected initial public offering in a few years.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app